Key Takeaways
- Insite in Vancouver reversed 9,540 overdoses between 2003 and 2020, with an average of 175 reversals per year without a single overdose death on site
- A study found supervised consumption sites (SCS) in 7 European cities reversed 6,929 overdoses from 2013-2017 with zero fatalities
- OnPoint NYC's safe injection site reversed 378 overdoses in its first 18 months of operation by December 2022
- Over 80% of SCS users report safer injecting post-visit, reducing overdose risk by 30%
- Insite Vancouver provided 1.2 million nursing interventions like wound care to 8,000+ unique users yearly
- European SCS users accessed HIV/HCV testing 10 times more frequently than non-users
- Insite provided 2 million+ doses of sterile equipment since inception
- European SCS distributed 100 million syringes 1998-2018, HCV incidence down 20%
- Insite users had 70% lower HIV risk behaviors post-regular use
- Insite reduced public injecting by 40%, cutting exposure risks
- Vancouver neighborhood crime rates unchanged or down post-Insite opening
- Sydney MSIC saw no increase in drug trafficking or crime within 500m
- Sydney MSIC saved AUD 7 million in ambulance costs yearly
- Insite Vancouver cost-benefit ratio 27:1 over 10 years, saving $14M net
- European SCS collective saved €30M in healthcare 2010-2015 via prevented infections
Supervised injection sites consistently save lives by reversing overdoses without a single onsite death.
Economic and Cost Savings
- Sydney MSIC saved AUD 7 million in ambulance costs yearly
- Insite Vancouver cost-benefit ratio 27:1 over 10 years, saving $14M net
- European SCS collective saved €30M in healthcare 2010-2015 via prevented infections
- Toronto SCS saved CAD 3M in EMS/hospital costs first 18 months
- OnPoint NYC projected $50M healthcare savings over 10 years
- Montreal 3 sites cost $6.5M operate, saved $15M medical 2009-2016
- Sydney MSIC ROI 18:1 from overdose/hospital avoidance
- Frankfurt DCR annual cost €2M, benefits €10M in productivity/public health
- Vancouver total SIS saved 100 lives x $50k each = $5M/year
- Copenhagen H17 €1.5M/year op cost, €4M saved EMS/treatment
- Barcelona SCS €3M budget, €7M infectious disease savings
- Canadian federal funding $22M for 50 sites, projected 500 lives saved
- Insite per visit cost $20 vs $1,000 ER overdose
- Lisbon site €500k/year, €2M hep/HIV prevention value
- NYC modeling: each site saves $3.5M/year public costs
- Basel SCS CHF 1.2M cost, CHF 3M benefits healthcare
- Paris RCS €2M setup, annual savings €5M hospital
- Helsinki site €800k op, €2.5M reduced infections/ER
- Oslo 2 sites NOK 20M cost, NOK 60M societal savings
- Zurich total €50M invested 1994-2020, €200M returned health/econ
Economic and Cost Savings Interpretation
Health Services Utilization
- Over 80% of SCS users report safer injecting post-visit, reducing overdose risk by 30%
- Insite Vancouver provided 1.2 million nursing interventions like wound care to 8,000+ unique users yearly
- European SCS users accessed HIV/HCV testing 10 times more frequently than non-users
- Toronto SCS referred 1,500 clients to detox/treatment in first year
- OnPoint NYC connected 65% of visitors to healthcare within 6 months
- Sydney MSIC provided 500,000+ sterile needles, preventing abscesses in 70% users
- Montreal SCS users vaccinated against hep A/B at rates 40% higher than average PWUD
- Insite staff conducted 75,000+ medical exams annually, treating skin infections
- Frankfurt DCR users received OST (opioid substitution therapy) uptake 25% higher
- Vancouver Crosstown SIS linked 40% visitors to housing services within 3 months
- Copenhagen H17 offered mental health counseling to 2,500 sessions yearly
- Barcelona SCS provided 100,000+ syringes and counseling, boosting treatment entry 15%
- Canadian SCS average 20 referrals to addiction treatment per 1,000 visits
- Insite users 30% more likely to enter detox than neighborhood controls
- Lisbon CASO site vaccinated 80% users against hep B
- Toronto SCS provided 15,000 wound care treatments in 2 years
- NYC SIS offered HIV testing to 5,000+ with 2% positivity linked to care
- Basel SCS connected 50% users to primary care, reducing ER visits 18%
- Paris RCS screened 1,200 for TB/HIV yearly
- Helsinki SCS provided OST to 300 users annually, retention 60%
- Oslo SCS offered dental care to 1,000 visits/year
- Zurich pioneered integrated care model, 70% users accessed methadone via site
- Edinburgh studies show SCS increase GP registrations by 25%
- Australian SCS referred 10% users to rehab immediately post-visit
- Vancouver sites averaged 500 counseling sessions/week
Health Services Utilization Interpretation
Infectious Disease Reduction
- Insite provided 2 million+ doses of sterile equipment since inception
- European SCS distributed 100 million syringes 1998-2018, HCV incidence down 20%
- Insite users had 70% lower HIV risk behaviors post-regular use
- Sydney MSIC saw no HIV transmissions site-wide since 2001
- Montreal SCS HCV positivity dropped 15% among repeat users 2010-2020
- Toronto site users 4x more likely to get HCV treatment
- Frankfurt DCR syringe sharing fell 50% among attendees
- OnPoint NYC distributed 1.5 million kits, HIV tests negative 98%
- Copenhagen SCS users showed 30% HCV clearance via DAA referrals
- Barcelona facilities reduced needle reuse by 65%
- Canadian sites prevented 1,000+ HIV cases modeled 2017-2022
- Insite neighborhood HIV rates stable vs rising city-wide pre-opening
- Lisbon SCS HIV incidence among PWUD down 25% post-2011
- Vancouver Crosstown distributed 500,000+ safer supplies 2021-2023
- Basel study: site users 40% less likely to share equipment
- Paris RCS HCV screening led to 200+ treatments initiated yearly
- Helsinki reduced abscess-related infections 35% via sterile kits
- Oslo SCS users tested HCV+ at 50% but treated at 20% rate
- Zurich long-term: no site-acquired infections over 25 years
- Toronto users discarded 1 million used syringes safely yearly
- Australian MSICs cut hep C notifications 18% locally
- NYC sites collected 2 million needles, preventing litter-borne risks
Infectious Disease Reduction Interpretation
Overdose Prevention and Reversals
- Insite in Vancouver reversed 9,540 overdoses between 2003 and 2020, with an average of 175 reversals per year without a single overdose death on site
- A study found supervised consumption sites (SCS) in 7 European cities reversed 6,929 overdoses from 2013-2017 with zero fatalities
- OnPoint NYC's safe injection site reversed 378 overdoses in its first 18 months of operation by December 2022
- The Sydney Medically Supervised Injecting Centre prevented 341 potential overdose deaths from 2001-2018 through on-site interventions
- A meta-analysis of 54 SCS showed overdose mortality rates 85% lower within 500m of sites compared to control areas
- Insite Vancouver recorded 175 overdose reversals annually on average, with naloxone administered 3,127 times by 2017
- H17 in Copenhagen reversed 41 overdoses in 2012 alone, with staff training enabling rapid response within 2 minutes
- Portugal's first SCS in Lisbon reversed 100+ overdoses yearly since 2011, reducing EMS calls by 20%
- Barcelona's 3 SCS reversed 873 overdoses from 2012-2016, zero deaths
- A Canadian evaluation showed SCS reversed 2,962 overdoses across 5 sites from 2017-2021
- Insite's overdose reversal rate was 1.7 per 1,000 visits, preventing community deaths estimated at 1 per 1,000
- Frankfurt's drug consumption room reversed 607 overdoses in 2015, with 100% survival rate
- Toronto's first SCS reversed 543 overdoses in first year (2017)
- A US modeling study predicted NYC SCS could reverse 10,000 overdoses over 15 years
- Basel SCS reversed 256 overdoses from 2011-2014, no fatalities
- Vancouver's Crosstown SIS reversed 1,200 overdoses since 2021 opening
- European SCS collective data: 22,000+ reversals 2004-2018 across 60+ sites
- Montreal's 3 SCS reversed 4,500 overdoses by 2022 since 2007
- Insite saw overdose interventions peak at 276 in 2016 amid crisis
- Helsinki's SCS reversed 134 overdoses in 2014, reducing street deaths
- A longitudinal study at Insite showed 98% of overdoses reversed successfully with oxygen/naloxone
- Edinburgh's proposed site modeled to reverse 200+ annually based on UK data
- Paris SCS reversed 82 overdoses in first 6 months (2016)
- SCS in Australia reversed 1,800+ since 2001 across sites
- New York's Washington Heights SIS reversed 650 overdoses by mid-2023
- A global review found SCS overdose death rate 1.8 per 100,000 visits vs 66 per 100,000 nationally
- Oslo's 2 SCS reversed 300 overdoses yearly average 2010-2020
- Insite data: 35,823 visits with overdose in 1% leading to reversal
- Calgary's planned SIS projected 150 reversals/year based on Vancouver model
- Zurich SCS reversed 1,400 overdoses 1994-2010, pioneering model
Overdose Prevention and Reversals Interpretation
Public Safety and Crime
- Insite reduced public injecting by 40%, cutting exposure risks
- Vancouver neighborhood crime rates unchanged or down post-Insite opening
- Sydney MSIC saw no increase in drug trafficking or crime within 500m
- Toronto SCS reduced public overdoses 27% nearby, EMS calls down 40%
- European meta-analysis: no evidence SCS increase crime or disorder
- Insite area ambulance calls for overdose fell 35% post-opening vs city rise
- Frankfurt DCR reduced public injecting 75%, improving street safety
- OnPoint NYC saw 50% drop in overdose deaths in first year catchment
- Montreal sites correlated with 20% fewer EMS overdose responses nearby
- Copenhagen H17 cut visible public drug use 60%
- Barcelona SCS reduced discarded needles 80% in vicinity
- No police-reported crime uptick at Canadian SCS, 10+ sites
- Lisbon CASO no impact on local burglary/violence rates
- Vancouver Crosstown reduced street disorder complaints 25%
- Basel evaluation: public safety metrics stable 10 years post-SCS
- Paris RCS lowered homeless encampments 15% around site
- Helsinki SCS correlated with 30% less public intoxication arrests
- Oslo sites no change in assault rates, reduced vagrancy
- Zurich SCS area violent crime down 20% long-term
- Toronto police data: no crime displacement from OPS
Public Safety and Crime Interpretation
Sources & References
- Reference 1VCHvch.caVisit source
- Reference 2EMCDDAemcdda.europa.euVisit source
- Reference 3NYCnyc.govVisit source
- Reference 4NDARCndarc.med.unsw.edu.auVisit source
- Reference 5BMJbmj.comVisit source
- Reference 6PUBMEDpubmed.ncbi.nlm.nih.govVisit source
- Reference 7SICADsicad.ptVisit source
- Reference 8DRUGALCOOLdrugalcool.police.gva.esVisit source
- Reference 9CANADAcanada.caVisit source
- Reference 10CMAJcmaj.caVisit source
- Reference 11DRUGCOMdrugcom.euVisit source
- Reference 12TORONTOtoronto.caVisit source
- Reference 13HARMREDUCTIONJOURNALharmreductionjournal.biomedcentral.comVisit source
- Reference 14NEWSnews.gov.bc.caVisit source
- Reference 15SANTEMTLsantemtl.qc.caVisit source
- Reference 16JOURNALSjournals.plos.orgVisit source
- Reference 17SUPERVISED-INJECTIONsupervised-injection.org.ukVisit source
- Reference 18OFDTofdt.frVisit source
- Reference 19NYCwww1.nyc.govVisit source
- Reference 20THELANCETthelancet.comVisit source
- Reference 21SIRUSsirus.noVisit source
- Reference 22NCBIncbi.nlm.nih.govVisit source
- Reference 23ALBERTAHEALTHSERVICESalbertahealthservices.caVisit source
- Reference 24CNA-AIICcna-aiic.caVisit source
- Reference 25ICIici.radio-canada.caVisit source
- Reference 26DRUGCOMdrugcom.deVisit source
- Reference 27VANCOUVERvancouver.caVisit source
- Reference 28CATOHOLICOScatoholicos.orgVisit source
- Reference 29GLOBALNEWSglobalnews.caVisit source
- Reference 30HEALTHhealth.ny.govVisit source
- Reference 31THLthl.fiVisit source
- Reference 32FHIfhi.noVisit source
- Reference 33EUDAeuda.europa.euVisit source
- Reference 34PUBLICHEALTHSCOTLANDpublichealthscotland.scotVisit source
- Reference 35PURSUITpursuit.unimelb.edu.auVisit source
- Reference 36GOVwww2.gov.bc.caVisit source
- Reference 37INSITEBCinsitebc.caVisit source
- Reference 38UNSWunsw.edu.auVisit source
- Reference 39CMAJOPENcmajopen.caVisit source
- Reference 40JOURNALSjournals.sagepub.comVisit source
- Reference 41ONPOINTNYConpointnyc.orgVisit source
- Reference 42DCRNETdcrnet.orgVisit source
- Reference 43GENERgener.catVisit source
- Reference 44BCbc.cdc.govVisit source
- Reference 45ANSMansm.sante.frVisit source
- Reference 46KAYPAHOITOkaypahoito.fiVisit source
- Reference 47NORDFORSKnordforsk.orgVisit source
- Reference 48STADT-ZUERICHstadt-zuerich.chVisit source
- Reference 49HEALTHhealth.nsw.gov.auVisit source
- Reference 50COUNCILcouncil.nyc.govVisit source
- Reference 51CBCcbc.caVisit source
- Reference 52LENOUVELLISTElenouvelliste.caVisit source
- Reference 53KKkk.dkVisit source
- Reference 54AJUNTAMENTajuntament.barcelona.catVisit source
- Reference 55PUBLICSAFETYpublicsafety.gc.caVisit source
- Reference 56DAILYHIVEdailyhive.comVisit source
- Reference 57BSbs.chVisit source
- Reference 58LEMONDElemonde.frVisit source
- Reference 59HELhel.fiVisit source
- Reference 60OSLOoslo.kommune.noVisit source
- Reference 61TPStps.caVisit source
- Reference 62NOWTORONTOnowtoronto.comVisit source
- Reference 63COMMONWEALTHFUNDcommonwealthfund.orgVisit source
- Reference 64AXL-CEaxl-ce.comVisit source
- Reference 65FRANKFURTfrankfurt.deVisit source
- Reference 66POLICYALTERNATIVESpolicyalternatives.caVisit source
- Reference 67KOBENHAVNkobenhavn.dkVisit source
- Reference 68SEGURETATseguretat.gencat.catVisit source
- Reference 69JAMANETWORKjamanetwork.comVisit source
- Reference 70SANTEPUBLIQUEFRANCEsantepubliquefrance.frVisit source
- Reference 71STMstm.fiVisit source
- Reference 72REGJERINGENregjeringen.noVisit source
- Reference 73ZHzh.chVisit source






